Literature DB >> 23295563

Distribution of pathogens in central line-associated bloodstream infections among patients with and without neutropenia following chemotherapy: evidence for a proposed modification to the current surveillance definition.

James P Steinberg1, Chad Robichaux, Sheri Chernetsky Tejedor, Mary Dent Reyes, Jesse T Jacob.   

Abstract

OBJECTIVE: Many bloodstream infections (BSIs) occurring in patients with febrile neutropenia following cytotoxic chemotherapy are due to translocation of intestinal microbiota. However, these infections meet the National Healthcare Safety Network (NHSN) definition of central line-associated BSIs (CLABSIs). We sought to determine the differences in the microbiology of NHSN-defined CLABSIs in patients with and without neutropenia and, using these data, to propose a modification of the CLABSI definition.
DESIGN: Retrospective review.
SETTING: Two large university hospitals over 18 months.
METHODS: All hospital-acquired BSIs occurring in patients with central venous catheters in place were classified using the NHSN CLABSI definition. Patients with postchemotherapy neutropenia (500 neutrophils/mm(3) or lower) at the time of blood culture were considered neutropenic. Pathogens overrepresented in the neutropenic group were identified to inform development of a modified CLABSI definition.
RESULTS: Organisms that were more commonly observed in the neutropenic group compared with the nonneutropenic group included Escherichia coli (22.7% vs 2.5%; P < .001) but not other Enterobacteriaceae, Enterococcus faecium (18.2% vs 6.1%; P = .002), and streptococci (18.2% vs 0%; P < .001). Application of a modified CLABSI definition (removing BSI with enterococci, streptococci, or E. coli) excluded 33 of 66 neutropenic CLABSIs and decreased the CLABSI rate in one study hospital with large transplant and oncology populations from 2.12 to 1.79 cases per 1,000 line-days.
CONCLUSIONS: Common gastrointestinal organisms were more common in the neutropenia group, suggesting that many BSIs meeting the NHSN criteria for CLABSI in the setting of neutropenia may represent translocation of gut organisms. These findings support modification of the NHSN CLABSI definition.

Entities:  

Mesh:

Year:  2012        PMID: 23295563     DOI: 10.1086/669082

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  11 in total

1.  Another look at CHG bathing in a surgical intensive care unit.

Authors:  Kyle J Popovich
Journal:  Ann Transl Med       Date:  2017-01

2.  What is the source of bloodstream infection due to vancomycin-resistant enterococci in persons with mucosal barrier injury?

Authors:  Mini Kamboj; Rachel Blair; Natalie Bell; Janet Sun; Janet Eagan; Kent Sepkowitz
Journal:  Infect Control Hosp Epidemiol       Date:  2014-01       Impact factor: 3.254

3.  Central line-associated bloodstream infections in neonates with gastrointestinal conditions: developing a candidate definition for mucosal barrier injury bloodstream infections.

Authors:  Susan E Coffin; Sarah B Klieger; Christopher Duggan; W Charles Huskins; Aaron M Milstone; Gail Potter-Bynoe; Bram Raphael; Thomas J Sandora; Xiaoyan Song; Danielle M Zerr; Grace M Lee
Journal:  Infect Control Hosp Epidemiol       Date:  2014-10-02       Impact factor: 3.254

Review 4.  Surveillance of bloodstream infections in pediatric cancer centers - what have we learned and how do we move on?

Authors:  Arne Simon; Rhoikos Furtwängler; Norbert Graf; Hans Jürgen Laws; Sebastian Voigt; Brar Piening; Christine Geffers; Philipp Agyeman; Roland A Ammann
Journal:  GMS Hyg Infect Control       Date:  2016-05-12

5.  Precision identification of diverse bloodstream pathogens in the gut microbiome.

Authors:  Fiona B Tamburini; Tessa M Andermann; Ekaterina Tkachenko; Fiona Senchyna; Niaz Banaei; Ami S Bhatt
Journal:  Nat Med       Date:  2018-10-15       Impact factor: 53.440

6.  Two-Year Hospital-Wide Surveillance of Central Line-Associated Bloodstream Infections in a Korean Hospital.

Authors:  Hye Kyung Seo; Joo-Hee Hwang; Myoung Jin Shin; Su Young Kim; Kyoung-Ho Song; Eu Suk Kim; Hong Bin Kim
Journal:  J Korean Med Sci       Date:  2018-10-04       Impact factor: 2.153

Review 7.  Update on infection control practices in cancer hospitals.

Authors:  Ella J Ariza-Heredia; Roy F Chemaly
Journal:  CA Cancer J Clin       Date:  2018-07-09       Impact factor: 508.702

Review 8.  Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO).

Authors:  Olaf Penack; Carolin Becker; Dieter Buchheidt; Maximilian Christopeit; Michael Kiehl; Marie von Lilienfeld-Toal; Marcus Hentrich; Marc Reinwald; Hans Salwender; Enrico Schalk; Martin Schmidt-Hieber; Thomas Weber; Helmut Ostermann
Journal:  Ann Hematol       Date:  2014-04-29       Impact factor: 3.673

9.  Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).

Authors:  C Gudiol; S Nicolae; C Royo-Cebrecos; M Aguilar-Guisado; I Montero; C Martín-Gandul; M Perayre; D Berbel; M Encuentra; M Arnan; J M Cisneros-Herreros; J Carratalà
Journal:  Trials       Date:  2018-05-02       Impact factor: 2.279

10.  Salmonella Typhimurium biofilm disruption by a human antibody that binds a pan-amyloid epitope on curli.

Authors:  Scott K Dessain; Çagla Tükel; Sarah A Tursi; Rama Devudu Puligedda; Paul Szabo; Lauren K Nicastro; Amanda L Miller; Connie Qiu; Stefania Gallucci; Norman R Relkin; Bettina A Buttaro
Journal:  Nat Commun       Date:  2020-02-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.